76-86 of 86
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
MinuteCE®Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
MinuteCE®Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
MinuteCE®Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Implementing CIDP Clinical Guidelines: Optimizing Therapy
MinuteCE®Implementing CIDP Clinical Guidelines: Optimizing Therapy
Nicholas J. Silvestri, MD
Jeffrey Allen, MD
Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
MinuteCE®Why Early and Accurate CIDP Diagnosis Matters: The Role of Standardized Tools
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CEDuchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
- advertisement
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
CME/CESpecial Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
Nilika Singhal, MD
M. Scott Perry, MD
Elizabeth Anne Thiele, MD, PhD
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CETitrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
Danielle Becker, MD, MS, FAES
Ahmed Abdelmoity, MD
Deborah Holder, MD
John Stern, MD
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
CME/CEEvolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
William Mencia, MD, FACEHP
Julie Blatt, MD
Taizo Nakano, MD
Novel Therapies to Manage OFF Episodes in Patients with Parkinson’s Disease
CME/CENovel Therapies to Manage OFF Episodes in Patients with Parkinson’s Disease
Robert A. Hauser, MD, MBA, FAAN
Stuart H. Isaacson, MD
Detangling Difficult Conversations About Multiple Sclerosis: Clinical Exchanges
CME/CEDetangling Difficult Conversations About Multiple Sclerosis: Clinical Exchanges
Patricia K. Coyle, MD
Clyde E. Markowitz, MD
- advertisement
